Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Remington

Showing results (141-150 of 2,715) with videos related to

Pageof 272
Sort By:
Assay and Drug Development Technologies|November 23, 2019
Re: "High-Content Screening Identifies New Inhibitors of Connexin 43 Gap Junctions" by Picoli <i>et al.</i> (<i>Assay Drug Dev Technol.</i> 2019;17:240-248)Remington L Nevin
The Journal of Dermatologic Surgery and Oncology|June 1, 1983
Argon laser therapy--rosacea, telangiectasiaB K Remington
Preventive Medicine|January 1, 1990
From preventive policy to preventive practiceR D Remington
The Pediatric Infectious Disease Journal|October 1, 1990
The tragedy of toxoplasmosisJ S Remington
The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Misclassification and Bias in Military Studies of MefloquineRemington Lee Nevin
Anesthesiology|June 22, 2016
Considerations in the Repositioning of Mefloquine for Anesthetic IndicationsRemington L Nevin
Physical Review. C, Nuclear Physics|May 1, 1987
n-p bremsstrahlung interpretation of high energy gamma rays from heavy-ion collisionsRemington, Blann, Bertsch
Circulation|December 1, 1979
Research related to validation of treatment modalities by large-scale clinical trialsR D Remington
Hypertension (Dallas, Tex. : 1979)|May 1, 1989
Potential impact of exclusion criteria on results of hypertension trialsR D Remington
Biology of Reproduction|July 28, 2012
Mefloquine gap junction blockade and risk of pregnancy lossRemington Lee Nevin
Pageof 272

Showing results (141-150 of 2,715) with videos related to

Sort By:
Pageof 272
Assay and Drug Development Technologies|November 23, 2019
Re: "High-Content Screening Identifies New Inhibitors of Connexin 43 Gap Junctions" by Picoli <i>et al.</i> (<i>Assay Drug Dev Technol.</i> 2019;17:240-248)Remington L Nevin
The Journal of Dermatologic Surgery and Oncology|June 1, 1983
Argon laser therapy--rosacea, telangiectasiaB K Remington
Preventive Medicine|January 1, 1990
From preventive policy to preventive practiceR D Remington
The Pediatric Infectious Disease Journal|October 1, 1990
The tragedy of toxoplasmosisJ S Remington
The American Journal of Tropical Medicine and Hygiene|July 19, 2017
Misclassification and Bias in Military Studies of MefloquineRemington Lee Nevin
Anesthesiology|June 22, 2016
Considerations in the Repositioning of Mefloquine for Anesthetic IndicationsRemington L Nevin
Physical Review. C, Nuclear Physics|May 1, 1987
n-p bremsstrahlung interpretation of high energy gamma rays from heavy-ion collisionsRemington, Blann, Bertsch
Circulation|December 1, 1979
Research related to validation of treatment modalities by large-scale clinical trialsR D Remington
Hypertension (Dallas, Tex. : 1979)|May 1, 1989
Potential impact of exclusion criteria on results of hypertension trialsR D Remington
Biology of Reproduction|July 28, 2012
Mefloquine gap junction blockade and risk of pregnancy lossRemington Lee Nevin
Pageof 272